Frequently asked questions about BioAFM

Do you have a question about BioAFM? This article will tell you everything you need to know.

Sen. Cassidy questions Lilly and Amgen on 340B restrictions on contract pharmacies

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 24, 2024

Pfizer pulls sickle cell treatment Oxbryta off global markets

Pfizer said Wednesday that it was removing Oxbryta, a pill for the treatment of sickle cell disease, from all markets globally due to high risks

September 25, 2024

Cell therapy startup ArsenalBio raises $325M as it runs early solid tumor trials

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.